Javascript must be enabled to continue!
Rate of Correction and All-Cause Mortality in Patients With Severe Hypernatremia
View through CrossRef
ImportanceHypernatremia is common among hospitalized patients and is associated with high mortality rates. Current guidelines suggest avoiding fast correction rates but are not supported by robust data.ObjectiveTo investigate whether there is an association between hypernatremia correction rate and patient survival.Design, Setting, and ParticipantsThis retrospective cohort study examined data from all patients admitted to the Tel Aviv Medical Center between 2007 and 2021 who were diagnosed with severe hypernatremia (serum sodium ≥155 mmol/L) at admission or during hospitalization. Statistical analysis was performed from April 2022 to August 2023.ExposurePatients were grouped as having fast correction rates (>0.5 mmol/L/h) and slow correction rates (≤0.5 mmol/L/h) in accordance with current guidelines.Main Outcomes and MeasuresAll-cause 30-day mortality.ResultsA total of 4265 patients were included in this cohort, of which 2621 (61.5%) were men and 343 (8.0%) had fast correction rates; the median (IQR) age at diagnosis was 78 (64-87) years. Slow correction was associated with higher 30-day mortality compared with fast correction (50.7% [1990 of 3922] vs 31.8% [109 of 343]; P < .001). These results remained significant after adjusting for demographics (age, gender), Charlson comorbidity index, initial sodium, potassium, and creatinine levels, hospitalization in an ICU, and severe hyperglycemia (adjusted odds ratio [aOR], 2.02 [95% CI, 1.55-2.62]), regardless of whether hypernatremia was hospital acquired (aOR, 2.19 [95% CI, 1.57-3.05]) or documented on admission (aOR, 1.64 [95% CI, 1.06-2.55]). There was a strong negative correlation between absolute sodium correction during the first 24 hours following the initial documentation of severe hypernatremia and 30-day mortality (Pearson correlation coefficient, −0.80 [95% CI, −0.93 to −0.50]; P < .001). Median (IQR) hospitalization length was shorter for fast correction vs slow correction rates (5.0 [2.1-14.9] days vs 7.2 [3.5-16.1] days; P < .001). Prevalence of neurological complications was comparable for both groups, and none were attributed to fast correction rates of hypernatremia.Conclusions and RelevanceThis cohort study of patients with severe hypernatremia found that rapid correction of hypernatremia was associated with shorter hospitalizations and significantly lower patient mortality without any signs of neurologic complications. These results suggest that physicians should consider the totality of evidence when considering the optimal rates of correction for patients with severe hypernatremia.
American Medical Association (AMA)
Title: Rate of Correction and All-Cause Mortality in Patients With Severe Hypernatremia
Description:
ImportanceHypernatremia is common among hospitalized patients and is associated with high mortality rates.
Current guidelines suggest avoiding fast correction rates but are not supported by robust data.
ObjectiveTo investigate whether there is an association between hypernatremia correction rate and patient survival.
Design, Setting, and ParticipantsThis retrospective cohort study examined data from all patients admitted to the Tel Aviv Medical Center between 2007 and 2021 who were diagnosed with severe hypernatremia (serum sodium ≥155 mmol/L) at admission or during hospitalization.
Statistical analysis was performed from April 2022 to August 2023.
ExposurePatients were grouped as having fast correction rates (>0.
5 mmol/L/h) and slow correction rates (≤0.
5 mmol/L/h) in accordance with current guidelines.
Main Outcomes and MeasuresAll-cause 30-day mortality.
ResultsA total of 4265 patients were included in this cohort, of which 2621 (61.
5%) were men and 343 (8.
0%) had fast correction rates; the median (IQR) age at diagnosis was 78 (64-87) years.
Slow correction was associated with higher 30-day mortality compared with fast correction (50.
7% [1990 of 3922] vs 31.
8% [109 of 343]; P < .
001).
These results remained significant after adjusting for demographics (age, gender), Charlson comorbidity index, initial sodium, potassium, and creatinine levels, hospitalization in an ICU, and severe hyperglycemia (adjusted odds ratio [aOR], 2.
02 [95% CI, 1.
55-2.
62]), regardless of whether hypernatremia was hospital acquired (aOR, 2.
19 [95% CI, 1.
57-3.
05]) or documented on admission (aOR, 1.
64 [95% CI, 1.
06-2.
55]).
There was a strong negative correlation between absolute sodium correction during the first 24 hours following the initial documentation of severe hypernatremia and 30-day mortality (Pearson correlation coefficient, −0.
80 [95% CI, −0.
93 to −0.
50]; P < .
001).
Median (IQR) hospitalization length was shorter for fast correction vs slow correction rates (5.
0 [2.
1-14.
9] days vs 7.
2 [3.
5-16.
1] days; P < .
001).
Prevalence of neurological complications was comparable for both groups, and none were attributed to fast correction rates of hypernatremia.
Conclusions and RelevanceThis cohort study of patients with severe hypernatremia found that rapid correction of hypernatremia was associated with shorter hospitalizations and significantly lower patient mortality without any signs of neurologic complications.
These results suggest that physicians should consider the totality of evidence when considering the optimal rates of correction for patients with severe hypernatremia.
Related Results
Hypernatremia in the intensive care unit
Hypernatremia in the intensive care unit
Purpose of review
Hypernatremia is a relatively frequent electrolyte disorder seen in critically ill patients. As many as 27% of patients in intensive care units (ICUs)...
Long-Term Developmental Assessment of Children Recovered from Hypernatremia
Long-Term Developmental Assessment of Children Recovered from Hypernatremia
Purpose: Imbalances in sodium result in acute neurologic symptoms such as seizures and impaired mental status. Studies investigating the long-term consequences of hypernatremia on ...
Relationship between hypernatremia & Intra-ventricular hemorrhage in very & extremely preterm neonates
Relationship between hypernatremia & Intra-ventricular hemorrhage in very & extremely preterm neonates
Abstract
Background and Objectives For identifying important risk factors that contribute to intra-ventricular hemorrhage (IVH) and hypernatremia in early postnatal life of...
The hyponatremias
The hyponatremias
Introduction: Plasma sodium concentrations are commonly measured in hospitalized patients. In our department, hypernatremia (defined as a serum sodium < 135 mmol/L) is usually a...
FREQUENCY OF HYPERNATREMIA SECONDARY TO ACUTE GASTROENTERITIS IN CHILDREN UNDER FIVE YEARS OF AGE
FREQUENCY OF HYPERNATREMIA SECONDARY TO ACUTE GASTROENTERITIS IN CHILDREN UNDER FIVE YEARS OF AGE
Background: Acute gastroenteritis remains a leading cause of morbidity and mortality among children under five years of age in developing countries. Electrolyte imbalances, particu...
Hipernatremia dan Penatalaksanaanya
Hipernatremia dan Penatalaksanaanya
Abstract: Hypernatremia could be caused by loss of water (increased loss or decreased intake), and although rarely, due to over intake of natrium. Patients who are at risk of hyper...
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
BACKGROUND
Suicide is a complex, serious and multifaceted public health issue that poses significant challenges to societies worldwide. In fact, it represen...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

